CLINICAL EVALUATION OF MEDOHAR GUGGULU AND ARJUN KWATH IN THE AYURVEDIC MANAGEMENT OF DYSLIPIDEMIA WSR MEDOROGA: A CASE STUDY

Dyslipidemia is a common metabolic disorder characterized by abnormal levels of serum lipids and is a major risk factor for cardiovascular diseases, obesity, and diabetes.[1] In Ayurveda, dyslipidemia can be correlated with Medoroga, which arises from Meda dhatu dushti and impaired function of Agni. The pathogenesis involves Kapha and Meda accumulation leading to Srotorodha (obstruction of channels) and systemic imbalance. While modern medicine highlights lipid abnormalities as central to disease progression.[2] Ayurvedic literature emphasizes nidana (etiology), samprapti (pathogenesis), and chikitsa (management) for holistic care.[3] Integrating both perspectives offers preventive and curative strategies that may improve clinical outcomes in managing dyslipidemia. A 29-year-old male patient was enrolled in the study to evaluate the therapeutic effect of Medohar Guggulu administered with Arjun Kwath as Anupana for one and half month. At the end of the intervention, the patient demonstrated marked reduction in clinical symptoms along with significant decreases in cholesterol, triglycerides, and VLDL levels.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-01
DOI
https://doi.org/10.5281/zenodo.17275466
Primary Topic
Maternal and fetal healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CLINICAL EVALUATION OF MEDOHAR GUGGULU AND ARJUN KWATH IN THE AYURVEDIC MANAGEMENT OF DYSLIPIDEMIA WSR MEDOROGA: A CASE STUDY

Zenodo (CERN European Organization for Nuclear Research)
Maternal and fetal healthcare
article

CLINICAL EVALUATION OF MEDOHAR GUGGULU AND ARJUN KWATH IN THE AYURVEDIC MANAGEMENT OF DYSLIPIDEMIA WSR MEDOROGA: A CASE STUDY

article en

Abstract

Dyslipidemia is a common metabolic disorder characterized by abnormal levels of serum lipids and is a major risk factor for cardiovascular diseases, obesity, and diabetes.[1] In Ayurveda, dyslipidemia can be correlated with Medoroga, which arises from Meda dhatu dushti and impaired function of Agni. The pathogenesis involves Kapha and Meda accumulation leading to Srotorodha (obstruction of channels) and systemic imbalance. While modern medicine highlights lipid abnormalities as central to disease progression.[2] Ayurvedic literature emphasizes nidana (etiology), samprapti (pathogenesis), and chikitsa (management) for holistic care.[3] Integrating both perspectives offers preventive and curative strategies that may improve clinical outcomes in managing dyslipidemia. A 29-year-old male patient was enrolled in the study to evaluate the therapeutic effect of Medohar Guggulu administered with Arjun Kwath as Anupana for one and half month. At the end of the intervention, the patient demonstrated marked reduction in clinical symptoms along with significant decreases in cholesterol, triglycerides, and VLDL levels.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 29%
Maternal and fetal healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CLINICAL EVALUATION OF MEDOHAR GUGGULU AND ARJUN KWATH IN THE AYURVEDIC MANAGEMENT OF DYSLIPIDEMIA WSR MEDOROGA: A CASE STUDY · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS